Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...

Individuals who are simultaneously taking certain antidepressants and beta blockers had a decrease in systolic blood pressure (BP) and an increase in their risk for bradycardia, according to new data ...

Women with epithelial ovarian cancer who happened to be taking nonselective beta-blockers for hypertension survived longer than those who were not taking the drugs, according to a large multicenter ...

Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...

Two systematic reviews revealed very low-certainty evidence on outcomes for people with gender dysphoria. (HealthDay News) — There is considerable uncertainty regarding the effects of puberty blockers ...